Results 131 to 140 of about 452,408 (160)
Spectrum of genetic mutations in methylmalonic aciduria among Iranian patients. [PDF]
Fathi M +3 more
europepmc +1 more source
The complexome contextualizes proteomics data to fingerprint biological states and highlight perturbed functional modules in disease. [PDF]
Guharoy M +22 more
europepmc +1 more source
Dissecting the role of vitamin B<sub>12</sub> metabolism in craniofacial development through analysis of clinical phenotypes and model organism discoveries. [PDF]
Pinales BE +4 more
europepmc +1 more source
Trauma-Focused Cognitive Behavioral Therapy Among Therapists Participating in Learning Collaboratives: Examining Two Implementation Strategies. [PDF]
Espeleta HC +4 more
europepmc +1 more source
Methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC) is the most frequent genetic disorder of vitamin B12 metabolism.
Celia Pérez-Cerdá +2 more
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Treatment of Cobalamin C (cblC) Deficiency During Pregnancy
Journal of Inherited Metabolic Disease, 2010AbstractObjectiveTo report the successful pregnancy of a woman with methylmalonic acidemia and hyperhomocysteinemia, cblC type [cobalamin C (cblC) deficiency] (MIM 277400).MethodRetrospective chart review.ResultsA 24‐year‐old woman presented at 14 weeks gestation with nausea, self‐restricted protein diet, and weight loss.
Grant A Mitchell +2 more
exaly +3 more sources
Glutathione metabolism in cobalamin deficiency type C (cblC)
Journal of Inherited Metabolic Disease, 2013AbstractBackgroundMethylmalonic aciduria with homocystinuria, cblC defect, is the most frequent disorder of vitamin B12 metabolism. CblC patients are commonly treated with a multidrug therapy to reduce metabolite accumulation and to increase deficient substrates.
Anna, Pastore +8 more
openaire +2 more sources
SSRN Electronic Journal, 2021
Background: Methylmalonic acid (MMA) combined with homocysteine (HCY) limits the survival and function of neurons during the development of cobalamin C (cblC) deficiency, yet no effective medication currently exists to ameliorate the damage. Methods: We designed a novel second-tier assay utilizing ultraperformance liquid chromatography-tandem mass ...
Zhou Wei +8 more
openaire +1 more source
Background: Methylmalonic acid (MMA) combined with homocysteine (HCY) limits the survival and function of neurons during the development of cobalamin C (cblC) deficiency, yet no effective medication currently exists to ameliorate the damage. Methods: We designed a novel second-tier assay utilizing ultraperformance liquid chromatography-tandem mass ...
Zhou Wei +8 more
openaire +1 more source
Molecular Genetics and Metabolism, 2023
In early-onset (EO) cblC deficiency (MMACHC), hydroxocobalamin dose-intensification (OHCBL-DI) improved biochemical and clinical outcome. In mammals, Cobalamin is reduced, in a reaction mediated by MMACHC. Pathogenic variants in MMACHC disrupt the synthesis pathway of methyl-cobalamin (MetCbl) and 5'-deoxy-adenosyl-cobalamin (AdoCbl), cofactors for ...
Scalais, Emmanuel +7 more
openaire +3 more sources
In early-onset (EO) cblC deficiency (MMACHC), hydroxocobalamin dose-intensification (OHCBL-DI) improved biochemical and clinical outcome. In mammals, Cobalamin is reduced, in a reaction mediated by MMACHC. Pathogenic variants in MMACHC disrupt the synthesis pathway of methyl-cobalamin (MetCbl) and 5'-deoxy-adenosyl-cobalamin (AdoCbl), cofactors for ...
Scalais, Emmanuel +7 more
openaire +3 more sources

